Akebia Therapeutics, Inc.
AKBA
Revenue
46.50M
▲9.07M▲24.23%
3 Months ChangeAssets
220.67M
▲13.53M▲6.53%
3 Months ChangeLiabilities
269.86M
▲12.31M▲4.78%
3 Months ChangeFree Cash Flow
-17.54M
▲4.20M▲19.31%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-22
Form 8-K
ID: 0001517022-24-000070
2024-10-16
Form 8-K
ID: 0001517022-24-000067
2024-08-08
Form 10-Q
ID: 0001628280-24-035879
2024-08-08
Form 8-K
ID: 0001517022-24-000065
2024-07-11
Form 8-K
ID: 0001517022-24-000061
2024-06-24
Form 8-K
ID: 0001517022-24-000059
2024-06-10
Form 8-K
ID: 0001517022-24-000057
2024-05-09
Form 10-Q
ID: 0001628280-24-021945
2024-05-09
Form 8-K
ID: 0001517022-24-000050
2024-04-23
Form 8-K
ID: 0001517022-24-000035